Healthcare
By
Is Gilead’s Experimental HIV Treatment Matching the Efficacy of Its Blockbuster Drug in Late-Stage Trials?
Foster City, California — Gilead Sciences has reported that its experimental HIV treatment has met the primary goal…
Is the White House (Trump) Expanding Its Drug Price Reduction Strategy with the Largest Round of Agreements Yet?
Washington, D.C. — The U.S. administration has announced a new set of agreements with nine pharmaceutical companies to…
Is Sanofi Strengthening Its Alzheimer’s Pipeline with a $1.04 Billion Partnership with South Korea’s ADEL?
Paris – Sanofi, the global pharmaceutical company, has announced a strategic collaboration with South Korea-based biotech ADEL to…
Could Roche’s Giredestrant Become the New Standard for Early-Stage ER-Positive Breast Cancer?
Basel, Switzerland – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the Phase III lidERA…
Has Sanofi’s Dupixent Been Approved for Pediatric Asthma in Japan?
Tokyo, Japan – December 23, 2025 Sanofi and Regeneron have received regulatory approval in Japan for Dupixent (dupilumab)…
Will Novartis’ $280M Gene Therapy Plant Transform Denton into a Biopharma Hub?
Denton, TX The Denton City Council has unanimously approved an economic development agreement with Novartis Gene Therapies, paving…
